How well can you actually predict which non-muscle-invasive bladder cancer patients will progress?
Eur Urol
.
2011 Sep;60(3):431-3; discussion 433-4.
doi: 10.1016/j.eururo.2011.06.001.
Epub 2011 Jun 12.
Author
Richard J Sylvester
PMID:
21680084
DOI:
10.1016/j.eururo.2011.06.001
No abstract available
Publication types
Editorial
Comment
MeSH terms
Adjuvants, Immunologic / administration & dosage*
BCG Vaccine / administration & dosage*
Humans
Neoplasm Recurrence, Local*
Urinary Bladder Neoplasms / therapy*
Substances
Adjuvants, Immunologic
BCG Vaccine